General Information


Dr. Baris graduated from medical school at Istanbul University in 2003. He completed pediatrics residency at Istanbul University, Cerrahpasa Medical Faculty in 2008. Dr. Baris completed his fellowship training in Pediatric Allergy and Immunology at Marmara University in 2012. He is currently serving as a Full-time Professor in the same division. His major interest in the field of primary immunodeficiencies (PIDs) and allergic diseases including clinical diagnose of cases, characterization of diseases and offer eligible therapeutic interventions. His group has been worked on the mechanism of several immunodysregulatory disorders, including IPEX, LRBA, CTLA4, DOCK8 deficiencies and STAT1-gain of function (GOF). He described for the first time the manifestation of lung involvement in human IPEX disease and showed the critical importance of this entity in disease outcome. Jointly with Dr. Chatila group from Harvard Medical School, he involved in the study of immune dysregulatory mechanisms in patients with STAT1-GOF. More recently, his group established an advance diagnostic and therapeutic PID center at Marmara University to enhance the diagnosis and research capacity for immune dysregulated patients. He is continuing to follow up immune dysregulated patients and work on new mechanisms that could have role on the pathogenesis of these diseases. In 2019, Dr. Baris was awarded the TUSEB Aziz Sancar Incentive Prize due to his important contributions to science at international level in the field of immunology.

Institutional Information

School of Medicine
Internal Medical Sciences
Department of Pediatrics